RECRUITING

Acupressure in Patients With Sickle Cell Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Official Title

Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease

Quick Facts

Study Start:2024-03-07
Study Completion:2029-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06511453

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any gender
  2. * 14-17 (Adolescents) and 18-80 (Adults) years old
  3. * Have been diagnosed with SCD and experiencing chronic pain in the past 6 months or vaso-occlusive crisis/crises in the past 12 months.
  4. * Either outpatient or inpatient or status changing between each other
  5. * Willing to limit the current and the introduction of any new medications or treatment modalities for control of pain symptoms during the study visits.
  6. * Willing to stick to the scheduled acupressure treatments every other day for 5 weeks.
  7. * Fluent in English and capable of giving written informed consent.
  1. * Recent/ongoing alternative pain management with acupuncture/acupressure or acupuncture/acupressure-related techniques within the last 6 months.
  2. * Presence of a concurrent autoimmune or inflammatory disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, etc. that causes pain or any other chronic pain condition with pain greater than sickle pain.
  3. * Diseases/conditions history includes but not limited to:
  4. * Head injury with substantial loss of consciousness
  5. * Known non-SCD-related severe psychiatric illnesses (e.g. current schizophrenia, major depression with suicidal ideation).
  6. * Significant visual, motor, or auditory impairment that would interfere with ability to perform study visits-related activities

Contacts and Locations

Study Contact

Ying Wang, MD, PhD
CONTACT
317-278-5045
ywa12@iu.edu
Ying Wang, MD, PhD
CONTACT

Study Locations (Sites)

University of California, Irvine
Irvine, California, 92868
United States
Indiana University School of Medicine
Indianapolis, Indiana, 46075
United States

Collaborators and Investigators

Sponsor: Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-07
Study Completion Date2029-08

Study Record Updates

Study Start Date2024-03-07
Study Completion Date2029-08

Terms related to this study

Keywords Provided by Researchers

  • Sickle Cell Disease
  • Pain
  • Acupressure
  • Inner Eyelid Imaging

Additional Relevant MeSH Terms

  • Sickle Cell Disease